Daniel Dornbusch (ddornbusch@mba2003.hbs.edu) leads the medical education team in Genentech?s Hematology Division. He previously worked for Genzyme, specializing in business, product, and corporate ...
From an approval for a disease affecting 900 people worldwide to a new drug class in multiple myeloma and a $322 million ...
Amplitude Therapeutics and Chai Discovery ink AI and RNA collaborations with Eli Lilly and Bristol Myers Squibb, Norstella's ...
Rohit Tripathi, VP of Industry Strategy at RELEX, lays out the five signals that he believes can measure if the tariff policy ...
K2 Therapeutics CEO Ying Huang discusses why government investment and US-trained returnees have made China's biotech ...
Chai Discovery has announced a collaboration with Bristol Myers Squibb to advance the discovery of therapeutic antibodies using artificial intelligence.
Rohit Tripathi, VP of Industry Strategy at RELEX, discusses how pharmaceutical reshoring demands end-to-end capability not ...
However, in a conversation with Norstella’s VP of thought leadership Dan Chancellor, he explained that pipeline creation has ...
Pharmaceutical reshoring is constrained by supplier qualification, process validation, FDA compliance readiness, workforce ...
A partnership roundup covers deals from IntraGel Therapeutics/UroGen Pharma and Lupin/Tenpoint Therapeutics, FDA approves ...
UroGen Pharma has invested in IntraGel Therapeutics and secured an exclusive option to license Tumocure, and Lupin's ...
President Trump has reportedly selected White House Domestic Policy Council deputy director Heidi Overton as his nominee for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results